ANDA 200265, held by Sandoz. Voriconazole.
As of Nov 21, 2026, ANDA 200265 (Voriconazole), held by Sandoz, was first approved by FDA on Dec 12, 2011, with 11 approved supplements and 0 published complete response letters.
Voriconazole tablets are an azole antifungal indicated for the treatment of adults and pediatric patients aged 12 to 14 years weighing greater than or equal to 50 kg and those aged 15 years and older regardless of body weight with: Invasive aspergillosis Candidemia in non-neutropenics and other deep tissue Candida infections Esophageal candidiasis Serious fungal infections caused by Scedosporium apiospermum and Fusarium species including Fusarium solani, in patients intolerant of, or refractory to, other therapy 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 12, 2011 | Original application | Approved | None posted |
| Voriconazole50MG · tablet;oral | Voriconazole | Rx |
| Voriconazole200MG · tablet;oral | Voriconazole | Rx |
| Dec 14, 2022 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 14, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jul 8, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jul 8, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 30, 2015 | Supplement 8Labeling · Standard review | Approved | None posted |
| Oct 30, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Dec 12, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters